A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.
about
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience.Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.Molecular profiling of childhood cancer: Biomarkers and novel therapiesCell survival signaling in neuroblastoma.The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.Emerging drugs for neuroblastoma.Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.Advances in emerging drugs for the treatment of neuroblastoma.Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.Inhibition of SN-38 glucuronidation by gefitinib and its metabolite.
P2860
Q33438641-2F4C7593-02B4-404C-A697-37500AE66A1FQ34781426-1A3D42BC-FEF4-42CE-8024-D0FD7EDC23FAQ35049970-255FA10C-73F1-4BD0-9DAE-2540AF19C55CQ36250783-A166DA03-6B9E-4E2D-A3A2-F143D70B4E0AQ37010166-A59017AE-68BE-4ADF-9B1D-38243613D792Q37444522-786DFA79-0D21-4C34-B3AD-36C8406A48DBQ37732332-C98E9B13-CBA4-4363-8C83-3F4E35B678EFQ38045441-6092DCCD-5FAE-483C-AB3D-CCDA2040C7FAQ38108399-A2781AED-3105-4E73-96DE-543E2CC5CB6EQ39113077-485A5843-EF26-410E-84B1-259D2F6D61C7Q39158415-0D2CEB79-6BA4-42CE-B5C0-700E08B85553Q40041609-3D7BE23D-D9EA-4ABD-AE0B-BD109F7C5973Q41008169-6EEE68F6-B01A-482E-BF87-B7B6A88B9D3A
P2860
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@ast
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@en
type
label
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@ast
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@en
prefLabel
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@ast
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@en
P2093
P2860
P1476
A single-arm pilot phase II st ...... nosed high-risk neuroblastoma.
@en
P2093
Andrew M Davidoff
Catherine A Billups
Clinton F Stewart
Dana Hawkins
Jianrong Wu
Lisa M McGregor
M Beth McCarville
Mihaela Onciu
Peter J Houghton
Sandy Kovach
P2860
P2888
P304
P356
10.1007/S10637-011-9724-3
P577
2011-07-28T00:00:00Z